Grenoble, France

Pascal Gayet

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pascal Gayet

Introduction

Pascal Gayet is a notable inventor based in Grenoble, France. He has made significant strides in the field of optical imaging, particularly in the development of fluorescent tracers for medical applications. His work focuses on enhancing the targeting of tumors, which is crucial for improving diagnostic and therapeutic techniques.

Latest Patents

Pascal Gayet holds a patent for a "Multivalent targeting fluorescent tracer in the near infrared range for optical imaging." This innovative fluorescent tracer is designed for targeting tumors and comprises at least one first fluorophore that fluoresces in a wavelength range of 700 to 1000 nm. The invention includes a targeting assembly with at least two identical targeting molecules and a cyclic oligopeptide. The design is configured to define a mean plane with a first upper face and a second lower face, featuring at least one first lysine amino acid residue on the second lower face. The targeting molecules are affixed to the first upper face, while the fluorophore is connected to the second lower face via a spacer arm, linking a carbon of the sequence of at least three double bonds to the lysine amino acid residue of the oligopeptide.

Career Highlights

Pascal Gayet is associated with Fluoptics, a company that specializes in advanced imaging technologies. His role at Fluoptics allows him to contribute to the development of innovative solutions that enhance the capabilities of optical imaging in medical diagnostics.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Pascal Gayet's contributions to the field of optical imaging through his patented inventions demonstrate his commitment to advancing medical technology. His work has the potential to significantly impact tumor targeting and imaging techniques, paving the way for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…